Health
COVID-19 vaccine developed by German research group fails in early trial – TheChronicleHerald.ca
FRANKFURT (Reuters) – A coronavirus vaccine developed by the German Centre for Infection Research (DZIF) and vaccine maker IDT Biologika did not prompt the hoped-for…
FRANKFURT (Reuters) – A coronavirus vaccine developed by the German Centre for Infection Research (DZIF) and vaccine maker IDT Biologika did not prompt the hoped-for immune reaction in early-stage testing on humans, trial organisers at university hospital Hamburg-Eppendorf (UKE) said on Friday.
Further testing has been suspended until the cause for the weak immunogenicity in the Hamburg trial involving 30 volunteers has been established, UKE said in a statement, adding that the vaccine was well…
-
General23 hours agoOf saints and sinners | The Spectator Australia
-
General23 hours agoSmall plane crashes into San Diego neighbourhood, setting homes and vehicles on fire
-
Noosa News13 hours agoTully Sugar Mill celebrates 100 years of cane harvesting amid floods and cyclones
-
General23 hours agoWhy the nation needs the Nationals to ditch Net Zero